Superiority of ArTiMist Versus Quinine in Children With Severe Malaria
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate that ArTiMist (sublingual artemether spray) is
better than intravenous quinine in reducing parasite counts by >= 90% within 24 hours after
the start of treatment in children with severe malaria, or uncomplicated malaria with
gastrointestinal complications